CHOLOGRAFIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Cholografin Sodium patents expire, and what generic alternatives are available?
Cholografin Sodium is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in CHOLOGRAFIN SODIUM is iodipamide sodium. There is one drug master file entry for this compound. Additional details are available on the iodipamide sodium profile page.
Summary for CHOLOGRAFIN SODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 14 |
Patent Applications: | 93 |
DailyMed Link: | CHOLOGRAFIN SODIUM at DailyMed |
US Patents and Regulatory Information for CHOLOGRAFIN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | CHOLOGRAFIN SODIUM | iodipamide sodium | INJECTABLE;INJECTION | 009321-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |